Del Prato, S., et al., Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
Informacije o alergenima: Proizvedeno u pogonu u kome se prerauju i mleko, jaja, gluten, soja i jezgrasto voe.
fortified 300500 mg/kg) reduced MDA levels while increasing both SOD and CAT activity, effects consistent with neuroprotection
Injectable GHK-Cu has FDA safety concerns in the compounding setting, and InjectCo does not offer it
Over the past few decades, government initiatives like funding to increase the productivity of affinity chromatography beads like magnetic and agarose beads have benefited, improving technological capability and economic competitiveness
In May 2026, global experts officially changed the name for PCOS to polyendocrine metabolic ovarian syndrome (PMOS)